Cargando…

CD5-Negative, CD10-Negative Low-Grade B-Cell Lymphoproliferative Disorders of the Spleen

CD5-negative, CD10-negative low-grade B-cell lymphoproliferative disorders (CD5-CD10-LPD) of the spleen comprise a fascinating group of indolent, neoplastic, mature B-cell proliferations that are essential to accurately identify but can be difficult to diagnose. They comprise the majority of B-cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmieg, John J., Muir, Jeannie M., Aguilera, Nadine S., Auerbach, Aaron
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700451/ https://www.ncbi.nlm.nih.gov/pubmed/34940069 http://dx.doi.org/10.3390/curroncol28060430

Ejemplares similares

Post-Transplant Lymphoproliferative Disorder Presenting as CD20-Negative Plasmablastic Lymphoma in the Lung
por: Kaleem, Tasneem, et al.
Publicado: (2016)

Single-Fraction Radiotherapy for CD30(+) Lymphoproliferative Disorders
por: Gentile, Michelle S., et al.
Publicado: (2015)

Genomic Analysis of Cutaneous CD30-Positive Lymphoproliferative Disorders
por: Abdulla, Farah R., et al.
Publicado: (2021)

Methotrexate-induced CD30(+) T-cell lymphoproliferative disorder of the oral cavity
por: Saleh, Jamal Z., et al.
Publicado: (2016)

The Use of CD200 in the Differential Diagnosis of B-Cell Lymphoproliferative Disorders
por: Al-Zubaidi, Hanaan Kareem, et al.
Publicado: (2023)

CD3(+)CD4(-)CD8(-) (Double-Negative) T Cells in Inflammation, Immune Disorders and Cancer
por: Wu, Zhiheng, et al.
Publicado: (2022)

Cladribine and Fludarabine Nucleoside Change the Levels of CD Antigens on B-Lymphoproliferative Disorders
por: Cassano, Carlos, et al.
Publicado: (2010)

Remittance of primary cutaneous CD30(+) lymphoproliferative disorder in a patient on adalimumab
por: Ottevanger, Rosanne, et al.
Publicado: (2022)

Cooccurrence of CD10-Positive and CD10-Negative Mantle Cell Lymphoma Complicated With Central Nervous System Involvement Solely by CD10-Positive Population
por: Fukushima, Noriyasu, et al.
Publicado: (2022)

Pediatric Lymphoid and Histiocytic Lesions in the Head and Neck
por: Auerbach, A., et al.
Publicado: (2021)

CD30-Positive T-Cell Lymphoproliferative Disease of the Oral Mucosa in Children: A Manifestation of Epstein-Barr Virus-Associated T-Lymphoproliferative Disorder
por: Hong, Mineui, et al.
Publicado: (2015)

CD30-positive primary cutaneous lymphoproliferative disorders: molecular alterations and targeted therapies
por: Prieto-Torres, Lucia, et al.
Publicado: (2019)

Case for diagnosis. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder
por: Valentim, Flávia de Oliveira, et al.
Publicado: (2019)

An accurate diagnosis of dermal CD8 (+) lymphoproliferative disorders requires clinicopathological and immunophenotypic correlation
por: Gru, Alejandro A.
Publicado: (2022)

Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder in an Unusual Location
por: Ruiz-Sánchez, Daniel, et al.
Publicado: (2022)

Angiolymphoid hyperplasia with eosinophilia developing in a patient with history of peripheral T-cell lymphoma: evidence for multicentric T-cell lymphoproliferative process
por: Gonzalez-Cuyar, Luis F, et al.
Publicado: (2008)

Cladribine with cyclophosphamide and prednisone in the management of low-grade lymphoproliferative malignancies
por: Laurencet, F M, et al.
Publicado: (1999)

Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS)
por: Lisco, Andrea, et al.
Publicado: (2019)

CD30+ Primary Cutaneous Post-transplant Lymphoproliferative Disorder with Signet-ring Cell Features
por: Malviya, Neeta, et al.
Publicado: (2016)

A case report of nodal CD4-positive T-cell lymphoproliferative disorder with an indolent course
por: Ge, Xiaowen, et al.
Publicado: (2018)

An Atypical Presentation of Primary Cutaneous CD4+ Small/Medium Pleomorphic T-Cell Lymphoproliferative Disorder
por: Kazan, Didem, et al.
Publicado: (2023)

Fcγ-Receptor IIIA Polymorphism p.158F Has No Negative Predictive Impact on Rituximab Therapy with and without Sequential Chemotherapy in CD20-Positive Posttransplant Lymphoproliferative Disorder
por: Zimmermann, Heiner, et al.
Publicado: (2014)

How to Diagnose and Treat CD5-Positive Lymphomas Involving the Spleen
por: Cabeçadas, José, et al.
Publicado: (2021)

Clinical and Laboratory Features of CD5-Negative Chronic Lymphocytic Leukemia
por: Demir, Cengiz, et al.
Publicado: (2017)

The Immune Regulatory Function of Lymphoproliferative Double Negative T Cells In Vitro and In Vivo
por: Ford, Megan S., et al.
Publicado: (2002)

Anti-nuclear antibody-negative immunoglobulin G4-associated autoimmune hepatitis mimicking lymphoproliferative disorders
por: Kang, Min Kyu, et al.
Publicado: (2020)

Fatal Case of EBV-negative Posttransplant Lymphoproliferative Disorder With Hemophagocytic Lymphohistiocytosis in an Adult Kidney Transplant Recipient
por: Mazzola Poli de Figueiredo, Sergio, et al.
Publicado: (2022)

IL-10 is Predominantly Produced by CD19(low)CD5(+) Regulatory B Cell Subpopulation: Characterisation of CD19 (high) and CD19(low) Subpopulations of CD5(+) B cells
por: Lee, Jae Ho, et al.
Publicado: (2011)

Dimensional Analysis of CD44(High) CD24(Low) and Ki67 in Triple Negative Breast Cancer
por: Tan, Betty, et al.
Publicado: (2019)

Corrigendum: Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS)
por: Lisco, Andrea, et al.
Publicado: (2019)

Primary cutaneous CD4+ small‐/medium‐sized T‐cell lymphoproliferative disorder: A case report
por: Koper, Monika, et al.
Publicado: (2019)

The potential differential diagnosis value and clinical significance of CD35 expression in B-chronic lymphoproliferative disorders
por: Shi, Yu, et al.
Publicado: (2021)

Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a case with multiple tumors()
por: Sarac, Esra, et al.
Publicado: (2023)

Biological Difference Between Epstein–Barr Virus Positive and Negative Post-transplant Lymphoproliferative Disorders and Their Clinical Impact
por: Ferla, Valeria, et al.
Publicado: (2020)

Autocrine IFNγ Controls the Regulatory Function of Lymphoproliferative Double Negative T Cells
por: Juvet, Stephen C., et al.
Publicado: (2012)

Multifocal CD4+ Primary Cutaneous Small/Medium Lymphoproliferative Disorder Successfully Treated With Low-Dose Oral Methotrexate: A Case Report
por: Dimassi, Ahmad B, et al.
Publicado: (2020)

IL-10-producing CD4(+) T cells negatively regulate fucosylation of epithelial cells in the gut
por: Goto, Yoshiyuki, et al.
Publicado: (2015)

STAT5 is Expressed in CD34(+)/CD38(−) Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms
por: Hadzijusufovic, Emir, et al.
Publicado: (2020)

Does it take three to tango? An unsuspected multimorbidity of CD8(+) T cell lymphoproliferative disorder, malaria, and EBV infection
por: Ekemen, Suheyla, et al.
Publicado: (2018)

COVID-19 Vaccine Pfizer-BioNTech: Recurrence of CD30-positive lymphoproliferative disorder: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dso3uf6spbkud2et52j5llllf1